Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
Blood. 2012 Jun 7;119(23):5359-66. doi: 10.1182/blood-2011-11-387324. Epub 2012 Feb 21.
Monoclonal gammopathy of undetermined significance (MGUS), a precursor to multiple myeloma (MM), is one of the most common premalignant conditions in the general population. The cause of MGUS is largely unknown. Recent studies show that there is an increased prevalence of MGUS in blood relatives of persons with lymphoproliferative and plasma cell proliferative disorders, suggesting presence of shared underlying genetic influences. In the past few years, additional studies have examined risk factors and biologic characteristics that may contribute to the increased prevalence of MGUS among relatives of probands with MGUS, MM, and other blood malignancies. This article reviews the known epidemiology and risk factors for familial MGUS and myeloma, the risk of lymphoproliferative disorders and other malignancies among blood-relatives of patients with MGUS and MM, and discusses future directions for research.
意义未明的单克隆丙种球蛋白血症(MGUS)是多发性骨髓瘤(MM)的前体,是普通人群中最常见的癌前状态之一。MGUS 的病因在很大程度上尚不清楚。最近的研究表明,在患有淋巴增生性和浆细胞增生性疾病的个体的血缘亲属中,MGUS 的患病率增加,提示存在共同的潜在遗传影响。在过去的几年中,其他研究已经检查了可能导致 MGUS 家族成员中 MGUS、MM 和其他血液恶性肿瘤患病率增加的危险因素和生物学特征。本文综述了已知的家族性 MGUS 和骨髓瘤的流行病学和危险因素、MGUS 和 MM 患者血缘亲属中淋巴增生性疾病和其他恶性肿瘤的风险,并讨论了未来的研究方向。